IRBs (Englisch)
- Neue Suche nach: Meinert, Curtis L.
- Neue Suche nach: Meinert, Curtis L.
In:
Clinical Trials Handbook
: Design and Conduct
;
159-162
;
2012
-
ISBN:
- Aufsatz/Kapitel (Buch) / Elektronische Ressource
-
Titel:IRBs
-
Beteiligte:Meinert, Curtis L. ( Autor:in )
-
Erschienen in:Clinical Trials Handbook : Design and Conduct ; 159-162
-
Verlag:
- Neue Suche nach: John Wiley & Sons, Inc.
-
Erscheinungsort:Hoboken, NJ, USA
-
Erscheinungsdatum:11.11.2012
-
Format / Umfang:3 pages
-
ISBN:
-
DOI:
-
Medientyp:Aufsatz/Kapitel (Buch)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis E-Book
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
TerminologyMeinert, Curtis L. et al. | 2012
- 5
-
DefinitionsMeinert, Curtis L. et al. | 2012
- 7
-
Measurement UnitsMeinert, Curtis L. et al. | 2012
- 9
-
Trial TypeMeinert, Curtis L. et al. | 2012
- 13
-
Design and Flow SchematicsMeinert, Curtis L. et al. | 2012
- 15
-
Design and Operating PrinciplesMeinert, Curtis L. et al. | 2012
- 17
-
Counting and Analysis RulesMeinert, Curtis L. et al. | 2012
- 19
-
Multi‐Study Umbrella NameMeinert, Curtis L. et al. | 2012
- 21
-
Study NameMeinert, Curtis L. et al. | 2012
- 25
-
ObjectiveMeinert, Curtis L. et al. | 2012
- 29
-
Specific aimsMeinert, Curtis L. et al. | 2012
- 31
-
Experimental VariableMeinert, Curtis L. et al. | 2012
- 33
-
Treatment UnitMeinert, Curtis L. et al. | 2012
- 35
-
Primary OutcomeMeinert, Curtis L. et al. | 2012
- 39
-
Outcome MeasuresMeinert, Curtis L. et al. | 2012
- 41
-
Design SynopsisMeinert, Curtis L. et al. | 2012
- 45
-
Type of Funding InitiativeMeinert, Curtis L. et al. | 2012
- 49
-
Funding: SpecificationsMeinert, Curtis L. et al. | 2012
- 51
-
Funding: TerminologyMeinert, Curtis L. et al. | 2012
- 59
-
Funding: TypeMeinert, Curtis L. et al. | 2012
- 61
-
Funding: InitiativeMeinert, Curtis L. et al. | 2012
- 63
-
Funding: PeriodMeinert, Curtis L. et al. | 2012
- 65
-
Funding: BudgetMeinert, Curtis L. et al. | 2012
- 67
-
Funding: ModeMeinert, Curtis L. et al. | 2012
- 69
-
Study GroupsMeinert, Curtis L. et al. | 2012
- 73
-
Comparison GroupMeinert, Curtis L. et al. | 2012
- 75
-
Study TreatmentsMeinert, Curtis L. et al. | 2012
- 77
-
Test TreatmentsMeinert, Curtis L. et al. | 2012
- 79
-
Control/Comparison TreatmentMeinert, Curtis L. et al. | 2012
- 87
-
Placebo TreatmentMeinert, Curtis L. et al. | 2012
- 91
-
Sham TreatmentMeinert, Curtis L. et al. | 2012
- 93
-
Treatment ModalityMeinert, Curtis L. et al. | 2012
- 95
-
Treatment ScheduleMeinert, Curtis L. et al. | 2012
- 97
-
Treatment Compliance MeasuresMeinert, Curtis L. et al. | 2012
- 101
-
Protocol OverridesMeinert, Curtis L. et al. | 2012
- 103
-
Protocol BailoutsMeinert, Curtis L. et al. | 2012
- 105
-
Mask/masking: DefinitionsMeinert, Curtis L. et al. | 2012
- 111
-
Masking PrinciplesMeinert, Curtis L. et al. | 2012
- 113
-
Masking, Censoring, and Shielding SpecificationsMeinert, Curtis L. et al. | 2012
- 115
-
Drug Masking ProcedureMeinert, Curtis L. et al. | 2012
- 117
-
Drug Packaging and LabelingMeinert, Curtis L. et al. | 2012
- 121
-
Drug SupplyMeinert, Curtis L. et al. | 2012
- 123
-
Masking SafeguardsMeinert, Curtis L. et al. | 2012
- 125
-
Unmasking Treatment AssignmentMeinert, Curtis L. et al. | 2012
- 127
-
Results BlackoutsMeinert, Curtis L. et al. | 2012
- 129
-
Bias Control ProceduresMeinert, Curtis L. et al. | 2012
- 135
-
StratificationMeinert, Curtis L. et al. | 2012
- 139
-
Variance Control ProceduresMeinert, Curtis L. et al. | 2012
- 141
-
SeparationsMeinert, Curtis L. et al. | 2012
- 143
-
Assignment Methods: Fixed vs. AdaptiveMeinert, Curtis L. et al. | 2012
- 147
-
Treatment Assignment: Random vs. NonrandomMeinert, Curtis L. et al. | 2012
- 151
-
Randomization: Complete vs. RestrictedMeinert, Curtis L. et al. | 2012
- 155
-
Randomization UnitMeinert, Curtis L. et al. | 2012
- 157
-
Randomization: ProceduresMeinert, Curtis L. et al. | 2012
- 159
-
IRBsMeinert, Curtis L. et al. | 2012
- 163
-
IRBs: Models and ProceduresMeinert, Curtis L. et al. | 2012
- 169
-
ConsentMeinert, Curtis L. et al. | 2012
- 177
-
Consent: ChecklistMeinert, Curtis L. et al. | 2012
- 181
-
Consent: Disclaimers and NotificationsMeinert, Curtis L. et al. | 2012
- 183
-
Consent: Principles and PurposeMeinert, Curtis L. et al. | 2012
- 185
-
Consent: ProcessMeinert, Curtis L. et al. | 2012
- 189
-
Consent: TypesMeinert, Curtis L. et al. | 2012
- 191
-
Consent: Questions and AnswersMeinert, Curtis L. et al. | 2012
- 195
-
NotationMeinert, Curtis L. et al. | 2012
- 199
-
Timing ConventionsMeinert, Curtis L. et al. | 2012
- 201
-
Required Approvals, Permissions, Accesses, and SuppliesMeinert, Curtis L. et al. | 2012
- 203
-
Start‐Up DesignMeinert, Curtis L. et al. | 2012
- 207
-
Start‐Up ChecklistMeinert, Curtis L. et al. | 2012
- 209
-
Recruitment DesignMeinert, Curtis L. et al. | 2012
- 211
-
Enrollment GoalsMeinert, Curtis L. et al. | 2012
- 213
-
Enrollment QuotasMeinert, Curtis L. et al. | 2012
- 217
-
Followup: TerminologyMeinert, Curtis L. et al. | 2012
- 221
-
Followup: MethodMeinert, Curtis L. et al. | 2012
- 223
-
Followup: LengthMeinert, Curtis L. et al. | 2012
- 225
-
Closeout DesignMeinert, Curtis L. et al. | 2012
- 229
-
Missed VisitMeinert, Curtis L. et al. | 2012
- 231
-
DropoutMeinert, Curtis L. et al. | 2012
- 235
-
Loss to FollowupMeinert, Curtis L. et al. | 2012
- 239
-
Study TimetableMeinert, Curtis L. et al. | 2012
- 241
-
Critical Event Path AnalysisMeinert, Curtis L. et al. | 2012
- 243
-
Eligibility CriteriaMeinert, Curtis L. et al. | 2012
- 245
-
Exclusions from EnrollmentMeinert, Curtis L. et al. | 2012
- 249
-
Eligibility and Exclusions by ReasonMeinert, Curtis L. et al. | 2012
- 251
-
Sample Size: DesignMeinert, Curtis L. et al. | 2012
- 257
-
Sample Size: SpecificationsMeinert, Curtis L. et al. | 2012
- 259
-
Sample Size: CalculationMeinert, Curtis L. et al. | 2012
- 261
-
Fixed vs. Sequential Sample Size DesignsMeinert, Curtis L. et al. | 2012
- 263
-
Fixed vs. Adaptive DesignsMeinert, Curtis L. et al. | 2012
- 265
-
Designed Subgroup ComparisonsMeinert, Curtis L. et al. | 2012
- 267
-
Contact ScheduleMeinert, Curtis L. et al. | 2012
- 271
-
Examinations/VisitsMeinert, Curtis L. et al. | 2012
- 275
-
Examination/Clinic Visit ScheduleMeinert, Curtis L. et al. | 2012
- 279
-
Data CollectionMeinert, Curtis L. et al. | 2012
- 281
-
Data Collection: Schedules and ProceduresMeinert, Curtis L. et al. | 2012
- 283
-
Data FlowMeinert, Curtis L. et al. | 2012
- 285
-
Data Processing ProceduresMeinert, Curtis L. et al. | 2012
- 287
-
Laboratory TestsMeinert, Curtis L. et al. | 2012
- 289
-
ReadingsMeinert, Curtis L. et al. | 2012
- 293
-
Tissue RepositoriesMeinert, Curtis L. et al. | 2012
- 295
-
Form Design: Principles and ProceduresMeinert, Curtis L. et al. | 2012
- 299
-
Time Window SpecificationsMeinert, Curtis L. et al. | 2012
- 301
-
Data Entry DesignMeinert, Curtis L. et al. | 2012
- 307
-
Data Sharing: InternalMeinert, Curtis L. et al. | 2012
- 311
-
Data Sharing: ExternalMeinert, Curtis L. et al. | 2012
- 315
-
Center TypesMeinert, Curtis L. et al. | 2012
- 323
-
CentersMeinert, Curtis L. et al. | 2012
- 325
-
Center RequirementsMeinert, Curtis L. et al. | 2012
- 329
-
Investigator RequirementsMeinert, Curtis L. et al. | 2012
- 333
-
Clinic Staffing RequirementsMeinert, Curtis L. et al. | 2012
- 335
-
Research Group/InvestigatorsMeinert, Curtis L. et al. | 2012
- 337
-
Key CommitteesMeinert, Curtis L. et al. | 2012
- 341
-
Standing and Working CommitteesMeinert, Curtis L. et al. | 2012
- 343
-
Committee Rules and ProceduresMeinert, Curtis L. et al. | 2012
- 347
-
Study OfficersMeinert, Curtis L. et al. | 2012
- 349
-
Study Chair/Vice‐ChairMeinert, Curtis L. et al. | 2012
- 353
-
Executive CommitteeMeinert, Curtis L. et al. | 2012
- 357
-
Executive Committee MembersMeinert, Curtis L. et al. | 2012
- 359
-
Steering CommitteeMeinert, Curtis L. et al. | 2012
- 361
-
Steering Committee MembersMeinert, Curtis L. et al. | 2012
- 363
-
Steering Committee: Questions, Answers, and ObservationsMeinert, Curtis L. et al. | 2012
- 367
-
Steering Committee Representation ModelsMeinert, Curtis L. et al. | 2012
- 371
-
Treatment Effects MonitoringMeinert, Curtis L. et al. | 2012
- 375
-
Treatment Effects Monitoring: PurposeMeinert, Curtis L. et al. | 2012
- 377
-
Treatment Effects Monitoring: ApproachMeinert, Curtis L. et al. | 2012
- 379
-
Treatment Effects Monitoring: MaskingMeinert, Curtis L. et al. | 2012
- 381
-
Stopping Rules and GuidelinesMeinert, Curtis L. et al. | 2012
- 383
-
Treatment Effects Monitoring: Questions and AnswersMeinert, Curtis L. et al. | 2012
- 387
-
Treatment Effects Monitoring CommitteeMeinert, Curtis L. et al. | 2012
- 391
-
Treatment Effects Monitoring Committee: Questions and AnswersMeinert, Curtis L. et al. | 2012
- 393
-
Quality Control and Assurance ProceduresMeinert, Curtis L. et al. | 2012
- 399
-
Performance MonitoringMeinert, Curtis L. et al. | 2012
- 401
-
Training ProceduresMeinert, Curtis L. et al. | 2012
- 403
-
Assurances and CertificationsMeinert, Curtis L. et al. | 2012
- 405
-
Site Visiting ProceduresMeinert, Curtis L. et al. | 2012
- 409
-
Audit ProceduresMeinert, Curtis L. et al. | 2012
- 413
-
Analysis DatasetsMeinert, Curtis L. et al. | 2012
- 417
-
Analysis Questions Regarding Study Results PublicationsMeinert, Curtis L. et al. | 2012
- 419
-
Frequentist vs. Bayesian AnalysisMeinert, Curtis L. et al. | 2012
- 421
-
Final AnalysisMeinert, Curtis L. et al. | 2012
- 423
-
Subgroup AnalysisMeinert, Curtis L. et al. | 2012
- 425
-
PublicationMeinert, Curtis L. et al. | 2012
- 429
-
Publication PolicyMeinert, Curtis L. et al. | 2012
- 431
-
AuthorshipMeinert, Curtis L. et al. | 2012
- 435
-
CreditsMeinert, Curtis L. et al. | 2012
- 439
-
Presentation PolicyMeinert, Curtis L. et al. | 2012
- 441
-
PoliciesMeinert, Curtis L. et al. | 2012
- 445
-
Publicity PolicyMeinert, Curtis L. et al. | 2012
- 447
-
Policy on Access to Study DocumentsMeinert, Curtis L. et al. | 2012
- 449
-
Policy on Access to Study Data and ResultsMeinert, Curtis L. et al. | 2012
- 453
-
Policy on Advertising for PatientsMeinert, Curtis L. et al. | 2012
- 455
-
Policy on Incentive PaymentsMeinert, Curtis L. et al. | 2012
- 457
-
Policy on Payment of Patient‐Related Travel ExpensesMeinert, Curtis L. et al. | 2012
- 459
-
Ancillary Study PolicyMeinert, Curtis L. et al. | 2012
- 461
-
Policy on Patient‐Care‐Related PaymentsMeinert, Curtis L. et al. | 2012
- 463
-
Policy on Conflicts of InterestMeinert, Curtis L. et al. | 2012
- 467
-
Substudy PolicyMeinert, Curtis L. et al. | 2012
- 469
-
Adverse EventsMeinert, Curtis L. et al. | 2012
- 475
-
Adverse Event Reporting ProceduresMeinert, Curtis L. et al. | 2012
- 479
-
Key Study DocumentsMeinert, Curtis L. et al. | 2012
- 485
-
Slide SetsMeinert, Curtis L. et al. | 2012
- 487
-
Study CVMeinert, Curtis L. et al. | 2012
- 489
-
Study WebsiteMeinert, Curtis L. et al. | 2012
- 491
-
Study History LogMeinert, Curtis L. et al. | 2012
- 493
-
Landmark Events and DatesMeinert, Curtis L. et al. | 2012
- 495
-
RegistrationMeinert, Curtis L. et al. | 2012
- 497
-
Appendix 1: Design Summaries for Selected Finished TrialsMeinert, Curtis L. et al. | 2012
- 517
-
Appendix 2: Sample Design Slide SetsMeinert, Curtis L. et al. | 2012
- 537
-
Appendix 3: Template Summary WorksheetMeinert, Curtis L. et al. | 2012
- 551
-
ReferencesMeinert, Curtis L. et al. | 2012
- 557
-
IndexMeinert, Curtis L. et al. | 2012
- i
-
FrontmatterMeinert, Curtis L. et al. | 2012